HomeAI · summaries
Storia in 2 fonti
Do people with obesity need to take a GLP-1 for the rest of their life?
Obesity is a chronic disease. This statement is clearly at the heart of the answer to this question. When you look at the data in the STEP 1 trial extension, semaglutide (Wegovy, Novo Nordisk) works very well. But among patients who stopped it, two-thirds regained most of their weight within a year. Then, when you look at the STEP 4 trial, which randomly assigned participants receiving
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Do people with obesity need to take a GLP-1 for the rest of their life?
Obesity is a chronic disease. This statement is clearly at the heart of the answer to this question. When you look at the data in the STEP 1 trial extension, semaglutide (Wegovy,…
- ·
Maintaining weight loss in obesity goes beyond GLP-1s: ‘The hard work is just beginning’
Lifestyle intervention remains a core component of obesity management, alongside the emergence of more potent pharmacotherapy.The FDA approval of obesity drugs including…
